Newpong Co., Ltd., a specialized developer of medical ultrasound systems, announced today the official launch of 'VIGENEA', its next-generation radiofrequency (RF) medical device, at the Annual Congress of the Straight Korean Association of Obstetricians and Gynecologists, to be held on October 18 at the Swiss Grand Hotel in Seoul.
VIGENEA is engineered to deliver RF energy through insulated micro-needles while the target tissue is stably anchored using proprietary vacuum technology. This approach optimizes both procedure safety and energy efficiency by ensuring precise depth control during thermal delivery.
Equipped with meticulously designed insulated micro-needle structures and multiple RF emission modes, VIGENEA features a versatile lineup of three specialized treatment tips. This configuration enables clinicians to tailor treatment protocols to individual patient profiles with high procedural accuracy.
At the congress exhibition, Newpong is demonstrating VIGENEA's core mechanics to medical professionals, focusing on its vacuum-assisted stability mechanism and precise RF energy control architecture.
"VIGENEA represents a significant step forward in procedural predictability and energy delivery efficiency," said a representative from Newpong. "Starting with this congress, we plan to deepen our engagement with clinicians while strengthening our technological competitive edge in the advanced RF medical device sector."
Building on its proprietary R&D capabilities in ultrasound technologies such as HIFU, Newpong continues to diversify its product portfolio to expand its footprint in the global aesthetic and therapeutic medical device market.
